UK law firms consider action on behalf of women who developed brain tumours after using contraceptive

Multiple studies show that women who take Depo-Provera have much higher risk of developing meningiomas

UK law firms are considering legal action on behalf of women who developed brain tumours after using the contraceptive injection Depo-Provera.

Depo-Provera is a high-dose synthetic progesterone, prescribed for contraception and other menstrual symptoms, administered via injection every three months. According to UN calculations, 74 million women worldwide and 3.1% of UK women aged 15-49 use injectable contraception.